237 filings
Page 10 of 12
10-Q
2021 Q2
GRI
GRI Bio Inc
Quarterly report
10 Aug 21
8:09am
8-K
GRI
GRI Bio Inc
10 Aug 21
Vallon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
8:06am
4
GRI
GRI Bio Inc
4 Jun 21
Vallon Pharmaceuticals / Leanne M. Kelly ownership change
4:06pm
4
GRI
GRI Bio Inc
27 May 21
Vallon Pharmaceuticals / Joseph E Payne ownership change
8:37pm
4
GRI
GRI Bio Inc
18 May 21
Vallon Pharmaceuticals / Joseph E Payne ownership change
4:09pm
4
Richard Ammer
18 May 21
Vallon Pharmaceuticals / Richard Ammer ownership change
4:08pm
4
Ofir Levi
18 May 21
Vallon Pharmaceuticals / Ofir Levi ownership change
4:08pm
4
GRI
GRI Bio Inc
18 May 21
Vallon Pharmaceuticals / Leanne M. Kelly ownership change
4:07pm
4
Penny Toren
18 May 21
Vallon Pharmaceuticals / Penny Toren ownership change
4:06pm
4
David Charles Baker
18 May 21
Vallon Pharmaceuticals / David Charles Baker ownership change
4:06pm
3
GRI
GRI Bio Inc
18 May 21
Vallon Pharmaceuticals / Leanne M. Kelly ownership change
4:05pm
10-Q
2021 Q1
GRI
GRI Bio Inc
13 May 21
Quarterly report
9:18am
8-K
GRI
GRI Bio Inc
13 May 21
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
8:45am
S-8
GRI
GRI Bio Inc
10 May 21
Registration of securities for employees
5:07pm
8-K
GRI
GRI Bio Inc
23 Apr 21
Departure of Directors or Certain Officers
4:40pm
8-K
GRI
GRI Bio Inc
14 Apr 21
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
12:00am
10-K
2020 FY
GRI
GRI Bio Inc
29 Mar 21
Annual report
9:01am
SC 13D/A
Pharma GmbH SALMON
16 Mar 21
Vallon Pharmaceuticals / SALMON Pharma GmbH ownership change
12:00am
8-K
GRI
GRI Bio Inc
26 Feb 21
Regulation FD Disclosure
4:37pm
8-K
GRI
GRI Bio Inc
16 Feb 21
Vallon Pharmaceuticals Announces Pricing of Initial Public Offering
6:02am